Purpose Numerous dose and fractionation schedules have been used to treat medically
inoperable stage I non-small cell lung cancer (NSCLC) with stereotactic body radiation …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Purpose The purpose of this study was to determine outcomes of patients with node-
negative medically inoperable non-small cell lung cancer (NSCLC) whose primary tumors …

This work is to analyze pooled clinical data using different radiobiological models and to
understand the relationship between biologically effective dose (BED) and tumor control …

Purpose The significance of clinical and dosimetric risk factors in relation to chest wall (CW)
injury after stereotactic body radiation therapy (SBRT) for lung tumors were analyzed …

Purpose A series of radiobiological models were developed to study tumor control
probability (TCP) for stereotactic body radiation therapy (SBRT) of early-stage non-small cell …

Objectives For this guideline, we investigated the effectiveness of radiotherapy with curative
intent in medically inoperable patients with early-stage non-small-cell lung cancer (nsclc) …

Background Radiation-induced chest wall pain (cwp) and rib fracture (rf) are late adverse
effects after stereotactic body radiation therapy (sbrt) for stage i non-small-cell lung cancer …

Patients with early-stage non–small-cell lung cancer (NSCLC) who are unable to undergo
surgery can be offered radiation therapy (RT). Previously, conventional RT was offered; …

Background We compared video‐assisted thoracoscopic surgery (VATS) lobectomy and
stereotactic body radiation therapy (SABR) to explore clinical outcomes in the treatment of …